Waters Corporation $WAT Shares Sold by Robeco Schweiz AG

Robeco Schweiz AG cut its stake in Waters Corporation (NYSE:WAT) by 15.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 128,250 shares of the medical instruments supplier’s stock after selling 23,945 shares during the period. Robeco Schweiz AG owned approximately 0.13% of Waters worth $56,352,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. California Public Employees Retirement System lifted its holdings in shares of Waters by 25.4% in the first quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock valued at $41,222,000 after buying an additional 28,074 shares during the period. Dudley & Shanley Inc. boosted its stake in Waters by 101.3% during the second quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier’s stock valued at $8,847,000 after buying an additional 11,870 shares in the last quarter. Ramsay Stattman Vela & Price Inc. bought a new position in Waters during the first quarter valued at about $942,000. Hahn Capital Management LLC bought a new position in Waters during the first quarter valued at about $1,490,000. Finally, Rockefeller Capital Management L.P. grew its holdings in Waters by 106.7% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,751 shares of the medical instruments supplier’s stock worth $1,045,000 after acquiring an additional 1,420 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

WAT opened at $453.42 on Friday. The firm has a market cap of $44.55 billion, a PE ratio of 113.07, a P/E/G ratio of 2.64 and a beta of 1.15. The company has a quick ratio of 1.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $424.37 and a 200-day simple moving average of $381.40. Waters Corporation has a fifty-two week low of $282.77 and a fifty-two week high of $465.36.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.01 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%. The company’s quarterly revenue was up 113.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.95 EPS. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. As a group, equities analysts predict that Waters Corporation will post 14.56 EPS for the current fiscal year.

Insider Buying and Selling at Waters

In related news, Director Christopher Kuebler sold 3,626 shares of Waters stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the transaction, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This trade represents a 16.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.31% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Piper Sandler upgraded shares of Waters from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $400.00 to $480.00 in a research report on Thursday, August 27th. Barclays raised their price objective on shares of Waters from $460.00 to $500.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. Weiss Ratings upgraded shares of Waters from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $400.00 price objective on shares of Waters in a research note on Wednesday, August 5th. Finally, UBS Group upgraded shares of Waters from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $375.00 to $490.00 in a report on Wednesday, September 9th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $443.79.

About Waters

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.